Trial record 1 of 30 for:    saracatinib
Previous Study | Return to List | Next Study

Safety and Tolerability of AZD0530 (Saracatinib) in Alzheimer's Disease

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Stephen M. Strittmatter, Yale University
ClinicalTrials.gov Identifier:
NCT01864655
First received: May 8, 2013
Last updated: June 12, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)